GSK to recruit clinical testee for cervix cancer vaccine.
Published: 2005-11-17 07:00:00
Updated: 2005-11-17 07:00:00
GSK Korea announced to recruit the clinical testee for the phase III clinical studies of HPV vaccine for the prevention of woman's cervix cancer, which was scheduled to perform at 8 hospitals across the nation including Seoul, Kwangju and Daegu.
The total patients will be 264 healthy girls wit...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
